Myo-Inositol Trispyrophosphate (ITPP) is a relatively new compound that improves the ability of haemoglobin in red blood cells to release oxygen into tissues. It has the chemical formula C6H15O15P3 and the molecular weight 420.096 g/mol.
ITPP Benefits and Uses
Myo-Inositol Trispyrophosphate (ITPP) is a recently discovered compound based on Myo-Inositol with significance in its ability to alter the oxygen-disassociation curve for haemoglobin in red blood cells. ITPP is of great interest to medical researchers studying the pathology of diseases related to hypoxia (low oxygen levels).
In animal trials, an acute and sustained impact on the oxygen binding affinity of hemoglobin was observed for 48 hours after a single administration of ITPP, and effects could still be seen in blood serum samples up to 12 days later! Anecdotally, many ITPP users have noted improved energy levels, an increase in exercise capacity, and a decrease in fatigue for up to a week following a single serving.
Research interest in ITPP is growing due to its energy-enhancing properties.
- Myo-Inositol Trispyrophosphate (ITPP) is known by a number of alternative names including:
- Inositol Tripyrophosphate
- Inositol 1,4,5-trisphosphate
- Myo Inositol Trispyrophosphate
- Sometimes confused for: Inositol Triphosphate (IT3)
- [(1R,2S,3R,4R,5S,6R)-2,3,5-trihydroxy-4,6-diphosphonooxycyclohexyl] dihydrogen phosphate
- IP3
Scientific Consensus
This is a relatively new product and there is very limited research on its effects and benefits in humans. Further research is necessary to fully understand the significance of its effects and adverse effects. Use with caution.
DO NOT EXCEED THE RECOMMENDED SERVING SIZE. Use with caution. Do not use if pregnant or breastfeeding.
PLEASE NOTE: ITPP is currently on the World Anti-Doping Agency list, and may NOT be used by professional athletes.
